AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Regulatory Filings Aug 8, 2019

4924_rns_2019-08-08_03c08984-b94f-4fa1-9895-71ae28f39f10.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3002I

Assura PLC

08 August 2019

8 August 2019

Assura plc

Note Issuance

Assura plc ("Assura" or the "Company"), the UK REIT and long-term investor in and developer of primary care property, is pleased to announce that it has raised £107 million of debt via the issue of privately placed notes.  The notes will be issued by Assura Financing plc, a wholly owned subsidiary of Assura. In line with Assura's funding strategy, the new notes are unsecured.

The notes carry a fixed rate of interest and will be issued in two series with maturities of 10 and 15 years: £47 million of the notes have been issued immediately and a further £60 million will be issued on 25 October 2019. The weighted average interest rate of both series is 2.30%.

Assura was advised on the private placement by Rothschild & Co.

Jayne Cottam, CFO, commented:

"We are delighted to have concluded this transaction at attractive rates and received support from our existing private placement lenders. This further reflects our strong financial position and the proceeds have been used to repay some of our drawings under our revolving credit facility.  These notes extend our maturity profile as well as reducing our weighted average cost of debt."

- Ends -

For more information, please contact:

Assura plc Tel: 01925 420660
Orla Ball, Company Secretary

David Purcell, Head of Financial Reporting
Finsbury Tel: 0207 251 3801
Gordon Simpson

James Thompson

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

Further information is available at www.assuraplc.com 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IODSSWFLWFUSEDA

Talk to a Data Expert

Have a question? We'll get back to you promptly.